首页> 外文期刊>Frontiers in Cellular and Infection Microbiology >Antimicrobial Resistance of Hypervirulent Klebsiella pneumoniae: Epidemiology, Hypervirulence-Associated Determinants, and Resistance Mechanisms
【24h】

Antimicrobial Resistance of Hypervirulent Klebsiella pneumoniae: Epidemiology, Hypervirulence-Associated Determinants, and Resistance Mechanisms

机译:高毒力肺炎克雷伯菌的耐药性:流行病学,与高毒力相关的决定因素和耐药机制。

获取原文
       

摘要

Klebsiella pneumoniae is one of the most clinically relevant species in immunocompromised individuals responsible for community-acquired and nosocomial infections, including pneumonias, urinary tract infections, bacteremias, and liver abscesses. Since the mid-1980s, hypervirulent K. pneumoniae, generally associated with the hypermucoviscosity phenotype, has emerged as a clinically significant pathogen responsible for serious disseminated infections, such as pyogenic liver abscesses, osteomyelitis, and endophthalmitis, in a generally younger and healthier population. Hypervirulent K. pneumoniae infections were primarily found in East Asia and now are increasingly being reported worldwide. Although most hypervirulent K. pneumoniae isolates are antibiotic-susceptible, some isolates with combined virulence and resistance, such as the carbapenem-resistant hypervirulent K. pneumoniae isolates, are increasingly being detected. The combination of multidrug resistance and enhanced virulence has the potential to cause the next clinical crisis. To better understand the basic biology of hypervirulent K. pneumoniae, this review will provide a summarization and discussion focused on epidemiology, hypervirulence-associated factors, and antibiotic resistance mechanisms of such hypervirulent strains. Epidemiological analysis of recent clinical isolates in China warns the global dissemination of hypervirulent K. pneumoniae strains with extensive antibiotic resistance in the near future. Therefore, an immediate response to recognize the global dissemination of this hypervirulent strain with resistance determinants is an urgent priority.
机译:肺炎克雷伯氏菌是免疫受损的个体中与临床最相关的物种之一,负责社区获得性和医院内感染,包括肺炎,尿路感染,菌血症和肝脓肿。自1980年代中期以来,高毒力肺炎克雷伯菌通常与高粘膜黏度表型有关,已成为一种临床上重要的病原体,在较年轻和较健康的人群中引起严重的播散性感染,例如化脓性肝脓肿,骨髓炎和眼内炎。高毒肺炎克雷伯菌感染主要在东亚发现,现在全世界越来越多地报道。尽管大多数高毒力肺炎克雷伯菌分离株对抗生素敏感,但越来越多地发现了一些具有综合毒力和耐药性的分离株,例如对碳青霉烯耐药的高毒力肺炎克雷伯菌分离株。多药耐药性和高毒力的结合可能导致下一次临床危机。为了更好地了解高毒力肺炎克雷伯菌的基本生物学,本综述将针对这种高毒力菌株的流行病学,与高毒力相关的因素以及抗生素耐药机制进行总结和讨论。对中国近期临床分离株的流行病学分析警告说,在不久的将来,全球范围内将广泛传播具有广泛抗生素耐药性的肺炎克雷伯菌。因此,立即做出反应以识别具有抗性决定簇的这种高毒力菌株的全球传播已成为当务之急。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号